How we work
We create powerful collaborations which overcome challenges to the advancement of the cell and gene therapy sector.
Wherever you are on your advanced therapy medicinal product (ATMP) development journey, we can help progress your products to market ensuring patients benefit from their immense potential
Supporting the needs of the sector
We support the advancement of the entire ATMP sector identifying its most critical drivers and aligning our activities to address these effectively. We are committed to delivering impact across four key areas:
New therapeutics
Supporting the development of novel ATMPs which provide effective treatments for more patients across a growing range of conditions.
Lower production costs
Driving innovation in manufacturing technologies to dramatically reduce production costs.
Strong supply
Establishing a robust and scalable manufacturing sector capable of meeting the demands of a rapidly growing industry and widespread ATMP adoption.
High patient uptake
Facilitating efficient adoption systems and aligning healthcare system reimbursement models with innovative therapies to ensure broader patient access on a global scale.
Learn more in our brochure
Advancing the cell and gene therapy industry through powerful collaborations
Working on a cell or gene therapy innovation challenge?
Contact us today to find out how we can support you.